In Brief: FDA Oversight hearing
Executive Summary
FDA Oversight hearing: Witnesses scheduled to testify June 19 before the House Commerce/Oversight Subcommittee include Tufts' Louis Lasagna, MD, Wilkes University's Arthur Kibbe, PhD, National Coalition for Cancer Survivorship Executive Director Ellen Stovall and Genzyme VP-Clinical, Medical & Regulatory Affairs Richard Moscicki, MD. Lasagna was previously scheduled to testify before the subcommittee May 25 but could not appear due to travel difficulties. Kibbe, while an official with the American Pharmaceutical Association, was one of three consultants who authored a report on the generic drug review process in 1991...